Investing Profile

Peter Thompson

InvestorVC

General Partner at OrbiMed Advisors

orbimed.comBellevue, Washington

Your Intro Paths to Peter Thompson

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Peter is a member of

Stealth Company (Sam Griffin) Network

244 CONNECTIONS

Stealth Company (Sam Griffin) Network

244 CONNECTIONS

Stealth Company (Sam Griffin) Network

244 CONNECTIONS

Stealth Company (Sam Griffin) Network

244 CONNECTIONS

Stealth Company (Sam Griffin) Network

244 CONNECTIONS

Find Peter Thompson on

Current Investing Position

OrbiMed Advisors General Partner

Investment Range

$1M - $75.0M

Sweet Spot

$4.0M

Investments On Record

Peter Thompson is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)BioTech (Series A)Seattle / Portland Health IT (Series A)Pharmaceuticals (Series A)New York City Health & Hospital Services (Series A)San Francisco Bay Area Diagnostics (Seed)Diagnostics (Series A)Health IT (Seed)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Peter Thompson's Investments On Record (19)

Company	StageDateRound Size	Total Raised
Terremoto Biosciences	Series CApr 2026$110M Series BNov 2023$180M Series AMay 2022$75M	$360M
Co-investors: Kevin Koch (OrbiMed), Reid Huber (Third Rock Ventures), Jeffrey Tong (Third Rock Ventures)
ProLynx	Series ADec 2025$70M	$70M
Co-investors: Kush Parmar (5am Ventures)
Ottimo Pharma	Series ADec 2024$140M	$140M
Co-investors: Mark Chin (Jmi Equity)
Sionna Therapeutics	Series CMar 2024$180M Series BApr 2022$110M	$290M
Co-investors: Bruce Booth (Atlas Venture)
ReCode Therapeutics	Series BSep 2023$50M Series BOct 2021$80M Series AMar 2020$80M	$210M
Co-investors: Helen Kim (Vida Ventures, LLC), Ed Hurwitz (MPM Capital), Rana Al-Hallaq (Pfizer Venture Investments), Kouki Harasaki (Ikigai BioVentures)
Aspen Neuroscience	Series BMay 2022$150M Series AApr 2020$70M SeedDec 2019$7M	$340M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Jonathan Silverstein (OrbiMed), Doug Fisher (InterWest), Kim P. Kamdar (Medical Excellence Capital, LLC), Sam Altman
Carrot Fertility	Series CAug 2021$75M	$120M
Co-investors: Reid Christian (CRV), Jay Chen (Tiger Global Management), Terrence Rohan (Index Ventures), Chloe Sladden (Broadway Angels), Carl Byers (F-Prime Capital (formerly Fidelity Biosciences)), Dafina Toncheva (U.S. Venture Partners (USVP)), Brad Flora (Y Combinator), Sara Thomas Deshpande (Maven Ventures), Arjun Sethi (Tribe-V Venture Capital), Stephanie Palmeri (NextView Ventures)
Janux Therapeutics	Series BApr 2021$130M Series AMar 2021$56M	$180M
Co-investors: Jay Lichter (Madrona Venture Group), Jake Simson (RA Capital Management)

Peter Thompson's Experience

CEO, Managing Director ATP CapitalPresent

CEO, Managing Director Stealth Company (Sam Griffin)Present

Venture Partner Stealth Company (Sam Griffin)Present

Co-Founder, Director ATP CapitalPresent

Co-Founder, Director Stealth Company (Sam Griffin)Present

Co-Founder, Chairman, CEO Stealth Company (Sam Griffin)Present

Chairman, Co-Founder ATP CapitalPresent

Chairman, Co-Founder Stealth Company (Sam Griffin)Present

VP, GM Chiron Informatics Chiron CorporationPresent

Affiliate Professor, Neurosurgery Center for Dialysis InnovationPresent

Affiliate Professor, Neurosurgery University of WashingtonPresent

Chairman of the Board Principia BiopharmaPresent

CEO, Managing Director Strategicon PartnersPresent

CEO, Managing Director TeamWorkPresent

Venture Partner ATP CapitalPresent

Venture Partner TeamWorkPresent

Co-Founder, Chairman, CEO Trubion PharmaceuticalsPresent

Venture Partner OrbiMed AdvisorsPresent

Co-Founder, Director Cleave BiosciencesPresent

Venture Partner OrbiMedPresent

Co-Founder, Director TeamWorkPresent

Private Equity Partner OrbiMed AdvisorsPresent

Partner OrbiMedPresent

Co-Founder, Director Corvus PharmaceuticalsPresent

Co-Founder, Chairman, CEO TeamWorkPresent

Co-Founder, Chairman, CEO Silverback TherapeuticsPresent

Co-Founder, Chairman Silverback TherapeuticsPresent

Chairman, Co-Founder Edgewise TherapeuticsPresent

Chairman, Co-Founder TeamWorkPresent

CEO, Co-Founder Terremoto BiosciencesPresent

General Partner OrbiMedPresent

General Partner OrbiMed AdvisorsPresent

Chairman, Co-Founder Terremoto BiosciencesPresent

Peter Thompson's Education

Brown University Sc.B. mathematics, molecular biology

Brown University Bachelor's Degree Molecular Biology, Mathematics

Brown Medical School M.D. medicine

Investors who invest with Peter Thompson

Scouts & Angels Affiliated With Peter Thompson